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http://dx.doi.org/10.1016/j.stemcr.2016.12.009SUMMARYAcquired genomic instability is one of the major concerns for the clinical use of induced pluripotent stem cells (iPSCs). All reprogram-
mingmethods are accompanied by the induction of DNA damage, of which double-strand breaks are themost cytotoxic andmutagenic.
Consequently, DNA repair genes seem to be relevant for accurate reprogramming tominimize the impact of such DNA damage. Here, we
reveal that reprogramming is associated with high levels of DNA end resection, a critical step in homologous recombination. Moreover,
the resection factor CtIP is essential for cell reprogramming and establishment of iPSCs, probably to repair reprogramming-induced DNA
damage. Our data reveal a new role for DNA end resection in maintaining genomic stability during cell reprogramming, allowing DNA
repair fidelity to be retained in both human and mouse iPSCs. Moreover, we demonstrate that reprogramming in a resection-defective
environment has long-term consequences on stem cell self-renewal and differentiation.INTRODUCTION
The ability to generate induced pluripotent stem cells
(iPSCs) has been heralded to have great potential in regen-
erative medicine and research (Yu et al., 2007; Takahashi
and Yamanaka, 2006). However, this potential is currently
under debate, due to evidence that iPSCs can acquire DNA
damage and genomic instability during the reprogram-
ming process (Ruiz et al., 2015; Liang and Zhang, 2013;
Gore et al., 2011; Mayshar et al., 2010). In fact, even just
expressing the reprogramming factors, regardless of the
methodology used to generate them, causes DNA damage,
mainly by replication stress (Ruiz et al., 2015; Gonzalez
et al., 2013; Tilgner et al., 2013). It is critical, however, to
obtain ‘‘safe’’ iPSCs that are genetically identical to their
parent cells for clinical use. An essential prerequisite for
this is to obtain a thorough understanding about how the
DNA repair machinery acts in these cells.
Several pieces of evidence suggest that pluripotent stem
cells need more active DNA repair pathways than somatic
differentiated cells (Rocha et al., 2013). Supporting this
view, members of the DNA damage response (DDR)
have been shown to prevent genomic instability in iPSCs
(Hong et al., 2009; Kawamura et al., 2009; Li et al., 2009).
Indeed, proteins involved in the repair of DNA double-
strand breaks (DSBs), in both homologous recombination
(HR) and non-homologous end joining (NHEJ), have a rele-
vant role in reprogramming efficiency (Gonzalez et al.,
2013; Ruiz et al., 2013; Tilgner et al., 2013). HR is required432 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017 j ª 2016 The A
This is an open access article under the CC BY-NC-ND license (http://creativfor an error-free repair of DSBs, using homologous se-
quences (normally from the sister chromatid) (Heyer
et al., 2010), and for restarting replication forks stalled dur-
ing replication stress (Petermann and Helleday, 2010). In
contrast, NHEJ competes with HR for DSB repair in a
more error-prone pathway (Gomez-Cabello et al., 2013;
Huertas, 2010; Lieber, 2008). DNA end resection is a key
event that regulates the DSB repair pathway choice be-
tween NHEJ and HR. This mechanism generates single-
strand DNA (ssDNA) by 50 to 30 degradation at both sides
of a break (Huertas and Jackson, 2009; Jackson and Bartek,
2009). Although resected DNA is an obligate substrate for
HR, it blocks NHEJ (Heyer et al., 2010). CtIP is a major
player in the decision between HR and NHEJ as it allows
for ssDNA formation, precluding binding of the NHEJ ma-
chinery to DNA breaks (Huertas, 2010). DNA end resection
is highly regulated bymultiple signals, including cell-cycle-
dependent CtIP phosphorylation (Sartori et al., 2007).
Cells depleted of CtIP fail to repair DNA DSBs by HR, are
sensitive to DNA damaging agents, and accumulate chro-
mosomal aberrations in response to DNA damage (Sartori
et al., 2007; Huertas and Jackson, 2009).
Here, we identified DNA end resection as one of the pre-
dominant mechanisms required for cell reprogramming in
human andmouse iPSCs (miPSCs), most likely based on its
function in repairing replication-induced DNA insults. In
addition, we have determined that CtIP is essential for re-
programming efficiency in both organisms. Cells deficient
for CtIP underwent apoptosis rather than reprogramming,uthor(s).
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Figure 1. DNA End Resection Is an Essential Mechanism for Cell Reprogramming
(A) FACS analysis of BrdU exposed by DNA end resection in MEFs and their respective reprogrammed cells (miPSCs). p Values were calculated
using the Kolmogorov-Smirnov test. At least three independent experiments were performed. Representative histogram is shown.
(B) Resected DNA length obtained by SMART technique in MEFs and miPSCs. Error bars indicate ±SEM of three independent experiments.
(C) Representative images of DNA fibers visualized with the anti-BrdU antibody.
(D) Same as (A) except using human foreskin fibroblasts (HFFs) and the human iPSCs (hiPSCs) derived from them. At least three inde-
pendent experiments were performed. Representative histogram is shown.
(E) Same as (B) except using human cells. Error bars indicate ±SEM of three independent experiments.
(F) Same as (C) except using human cells.
(legend continued on next page)
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probably due to an unbearable load of DNA damage during
the process. Those cells that could reprogram with low
levels of CtIP acquired a burden in terms of genomic muta-
tions that compromised their long-term survival and
ability to differentiate again. We suggest that CtIP has a
genomic stability protector role during reprogramming.
Exploiting such a role could contribute to creating geneti-
cally stable iPSCs that meet clinical safety standards for
use in regenerative medicine.RESULTS
DNA End Resection Increases in Mouse and Human
iPSCs
Cell reprogramming per se, by the expression of reprogram-
ming factors (OCT4, SOX2, KLF4, and c-MYC), increases
DNA damage and genetic instability, mainly by replication
stress (Ruiz et al., 2015). Here, we used a previously re-
ported mouse embryonic fibroblast (MEF) cell line bearing
the doxycycline-inducible system of mouse genes of Klf4,
Oct4, Sox2, and c-Myc to carry out the reprogramming pro-
cess (Abad et al., 2013). First, we analyzed cellular levels of
DNA end resection in MEFs and their corresponding iPSCs
generated by doxycycline treatment. We developed a new
strategy for a readout of DNA end resection based on bro-
modeoxyuridine (BrdU) detection by fluorescence-acti-
vated cell sorting (FACS) analysis using native conditions.
In contrast to standard proliferation assays using BrdU
incorporation, this assay is based on a BrdU epitope that
is hidden in double-stranded DNA, and thereby unavai-
lable to anti-BrdU antibodies under native conditions. Crit-
ically, the assay is non-responsive to DNA replication, and
the epitope is only exposed after formation of ssDNA by
resection. This novel method demonstrated that miPSCs
had more exposed BrdU than primary MEFs not treated
with doxycycline, showing that a higher amount of endog-
enously occurring breaks were resected in reprogrammed
cells (Figure 1A). We further confirmed that this increased
BrdU signal intensity was indeed due to canonical DNA
end resection, as it disappeared when the key resection
factor CtIP was depleted (Figure S1A).
These results demonstrated that the DNA end resection
process was activated in miPSCs in the absence of exoge-
nous damage, most likely due to replication stress and
DNAdamage generated during cell reprogramming.Wehy-
pothesized that this resection activation reflects not only(G) MEFs and miPSCs were immunoblotted to analyze the indicated
A representative western blot is shown.
(H) Same as (G) except showing protein levels in HFFs and hiPSCs.
sentative western blot is shown.
See also Figures S1–S3.
434 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017an increased number of breaks being processed, but also
a higher processivity of the resection machinery itself.
Thus, we analyzed whether the length of resected DNA
was longer in miPSCs than in MEFs, using a high-resolu-
tion technique to measure the length of resected DNA
in individual DNA fibers (Cruz-Garcia et al., 2014). We
demonstrated that miPSCs generated significantly longer
tracks of ssDNA compared with the primary differentiated
parent cells (Figures 1B and 1C). A 50% increase in the me-
dian length of resected DNA was observed in pluripotent
cells with respect their MEF control (Figures 1B and 1C).
Again, we could demonstrate that this was caused by acti-
vation of the canonical resection machinery, as this
increased length of ssDNA depended on CtIP activity (Fig-
ure S1C). Strikingly, the number of lesions and the amount
of resected DNA following reprogramming to iPSCs was
equivalent to that seen after treating primary cells with
high doses of exogenous damage (Figures S1B and S1C),
in agreement with the idea that this process represents a
severe challenge for genomic integrity.
To address whether the activation of resection during cell
reprogramming was evolutionarily conserved, we investi-
gated whether DNA end processing also increases during
reprogramming of primary human cells. We used four
retroviral vectors bearing one of the OSKM factors (OCT4,
SOX2, KLF4, or c-MYC) to generate human iPSCs (hiPSCs)
from human foreskin fibroblasts (HFFs). Similar to miPSCs,
hiPSCs showed both increased ssDNA-BrdU exposure, indi-
cating a higher number of resected DSBs (Figure 1D) and
longer resected tracks (Figures 1E and 1F) than the parental
HFF somatic cells, despite the lack of any exogenous source
of DNA damage. In fact, this effect in hiPSCs was more
exacerbated than in miPSCs, as hiPSCs had up to a 3-fold
gain on the length of resected DNA. All of our results
point toward a hyper-activation of DNA resection during
reprogramming in mouse and human cells, which likely
minimizes the impact of the DNA damage caused during
the process.CtIP Levels Increase in miPSCs and hiPSCs
CtIP activates DNA end processing in HR and is known to
be a major regulator of DNA end resection (Cruz-Garcia
et al., 2014;Wang et al., 2013; Nakamura et al., 2010; Huer-
tas and Jackson, 2009; Huertas et al., 2008; Sartori et al.,
2007). Indeed, we observed that CtIP was required for
the resection hyper-activation observed in miPSCs (Figuresproteins. At least three independent experiments were performed.
At least three independent experiments were performed. A repre-
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Figure 2. CtIP Deficiency Impairs Mouse Cell Reprogramming
(A) Doxycycline-inducible OSKM MEFs were transduced with shCtIP and shNT lentivirus prior to induction with doxycycline. Re-
programming efficiency was analyzed by counting the number of colonies in triplicate of each biological sample. Error bars indicate ±SEM
of a biological triplicate.
(B) Representative pictures of miPSC morphology.
(C) The sub-G1 peak was quantified in MEFs (–Dox) or reprogrammed MEFs at day 10 (+Dox) by FACS analysis in cells downregulated for CtIP
(black bars) or expressing a control shRNA (white bars). Error bars indicate ±SEM of three independent experiments.
(D) Representative cell-cycle plots of reprogrammed MEFs in each condition. At least three independent experiments were performed.
(legend continued on next page)
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S1A and S1C). Congruently, we observed that CtIP expres-
sion and protein levels increased in miPSCs with respect
to primary MEFs, concurrent with the expression of the
pluripotency marker Nanog (Figures 1G and S2A–S2C).
We confirmed by immunoblot that hiPSCs also incre-
mented the expression and protein levels of CtIP in a
concomitant manner to NANOG and OCT4 (Figures 1H,
S2D, and S2E). These results clearly suggested that the hy-
per-active DNA resection in iPSCs requires CtIP upregula-
tion during the reprogramming process, most likely to
manage an increased load of DSBs that have to be repaired
by HR. Thus, both mouse and human iPSCs showed
intrinsic increased levels of CtIP and DNA end resection
compared with their parent cells.
CtIP Is Required for Efficient Cell Reprogramming for
Both Mouse and Human Cells
To determine the relevance of CtIP and its upregulation
during cell reprogramming, we forced the induction pro-
cess in cells with reduced levels of the CtIP protein. For
this, we transduced MEFs with short hairpin RNA (shRNA)
lentivirus against CtIP or control shRNA (shNon-Target
[shNT]), which also contained the OSKM factors under
doxycycline induction, and then analyzed them for reprog-
ramming (Figure S2A). Three weeks after induction, we
observed a dramatic and significant reduction of the num-
ber of colonies with stem cell-like morphology in CtIP-
depleted cells comparedwith shNTcontrol cells (Figure 2A).
Moreover, CtIP-depleted colonies were smaller than con-
trol ones (Figure 2B). In agreement with results published
previously (Chen et al., 2005), and as a control of the
CtIP depletion effects in primary MEFs, we observed less
proliferation in CtIP-downregulated MEFs (Figure S3A).
However, this reduced proliferation was not associated
with an increase in sub-G1 phase cells (Figure 2C, –Dox),
even though, as expected, CtIP deficiency provoked a sig-
nificant increase in DNA damage, as measured by gH2ax
(Figures 2F and 2G). Interestingly, in agreement with
the idea that unrepaired DNA damage during cell reprog-
ramming triggers apoptosis as a consequence of genomic
instability, we observed that reprogrammed mouse cells
expressing an shRNA against CtIP showed a strong increase
in sub-G1 cells 10 days after doxycycline induction (Figures
2C and 2D), compared with either reprogrammed cells
expressing a control shRNA or MEFs depleted for CtIP.(E) Immunoblot of proactive and active/cleavage caspase-3 in repr
A representative western blot is shown of three independent experim
(F) FACS quantification of cells positive for gH2ax. Other details as in
(G) The indicated proteins were immunodetected in samples from OSK
A representative western blot is shown of three independent experim
t Test statistical analyses in (A), (C), and (F) were performed using a
See also Figures S2 and S3.
436 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017Further, we observed an increase of proteolytic cleavage
and activation of caspase-3 in reprogrammed MEFs with
short hairpin CtIP (shCtIP) at day 10 (Figure 2E), confirm-
ing that the increased levels of sub-G1 were indeed due to
induced apoptosis.
We also detected that the amount of the DNA damage
marker gH2ax increased slightly but significantly in cells
containing shCtIP versus those with shNT, as shown by
both FACS analysis and immunoblot (Figures 2F and 2G).
Even though this difference was also observed in MEFs, it
was more intense in reprogrammed cells, in agreement
with CtIP playing a more critical role in repairing DNA
damage during cell reprogramming. This suggests that
excessive damage prompted the observed induction of
apoptosis. Pluripotent statuswas confirmed by the observa-
tion of Nanog protein levels (Figures 2G, S2A, and S2C).
Efficient reprogramming requires functional repair path-
ways to favor an error-free dedifferentiation. In agreement
with this, DDR was activated during reprogramming pro-
cess, as shown by the increase in Chk1, gH2ax, and CtIP
protein levels (Figures 2G and S2A). Reprogrammed cells
that had downregulated CtIP also had increased DNA dam-
age levels compared with reprogrammed control cells at
10 days after doxycycline induction (Figure 2G), support-
ing the idea that replication stress causes DNA damage
and Chk1 activation during reprogramming (Ruiz et al.,
2015).
Congruently, hiPSCs obtained from HFF cells by expres-
sion of OSKM factors in the presence of an shRNA against
CtIP showed an increased sub-G1 peak (Figures 3A and
3B), an enrichment of the activated form of caspase-3 (Fig-
ure 3C) and elevated numbers of gH2AX-positive cells (Fig-
ure 3D), when compared with the same cells reprogramed
bearing a control shRNA. In addition, expressing shCtIP
constitutively during reprogramming completely blocked
iPSC colony generation, while expressing control shRNA
had no effects (not shown). We wondered whether this
strong effect was due to cell death caused by a lack of
CtIP in HFF cells (e.g., an excessive depletion of CtIP) or re-
flected a problem during reprogramming. Strikingly, CtIP
depletion in HFF cells without OSKM expression neither
changed their proliferation rate (Figure S3B) nor signifi-
cantly induced DNA damage or apoptosis, measured as
sub-G1 cells (Figures 3A and 3D). Thus, we conclude that
the lack of iPSCs was not caused by problems in HFF cells,ogrammed MEFs at day 10 (+Dox) bearing the indicated shRNAs.
ents.
(C).
M-induced MEFs after 10 days of continuous doxycycline treatment.
ents.
t least three independent experiments.
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Figure 3. CtIP Depletion Impairs Human Cell Reprogramming
(A) Percentage of cells in sub-G1 phase in HFF cells or those reprogrammed to iPSCs bearing either the control shRNA shNT (white bars)
or shCtIP (black bars). Error bars indicate ±SEM of three independent experiments. p Values were calculated using the t test. ns, not
significant.
(B) Representative FACS plots of cell-cycle analysis in reprogrammed HFF cells of each condition. At least three independent experiments
were performed.
(legend continued on next page)
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but by a critical role of CtIP in human cell reprogramming.
To confirm this relevant role, we next generated iPSCs with
limited CtIP downregulation by using an isopropyl b-D-1-
thiogalactopyranoside (IPTG)-inducible shRNA (shCtIP-
IPTG) and titrating IPTG concentration. Indeed, and
similar to miPSCs, HFF cells partially depleted of CtIP by
IPTG induction also formed fewer colonies, confirming
that they had an impaired reprogramming efficiency (Fig-
ure 3E). In addition, colonies partially deficient for CtIP
were smaller than control colonies (Figure 3F). Indeed,
although we were able to expand several clones from the
iPSCs with an IPTG-induced control shRNA (shNon-target
[shNT] clones), we only successfully expanded one clone of
iPSCs bearing the shCtIP-IPTG under IPTG induction (CtIP
C1 clone; Figure 3G). Interestingly, we could recover CtIP
expression on this clone by removing IPTG. As an addi-
tional control, we reprogrammed HFF cells containing
shCtIP-IPTG to iPSCs in the absence of IPTG (C4 clone)
(Figure 3G). Hence, by adding IPTG at different time
points, we could compare distinct states of HFF cells after
reprogramming: (1) reprogrammed in the absence of CtIP
(C1 clone); (2) reprogrammed in the presence of CtIP and
depleted of CtIP once pluripotency had been established
(C4 clone); and (3) always with CtIP (Figure 3G). Analyzing
these reprogrammed clones for chromosome number vari-
ation, we found that the C1 clone (reprogrammed without
CtIP) had a significant increase in chromosomal aberra-
tions, measured as aneuploidy, compared with those from
the other two conditions (Figure 3H). This is in agreement
with our results showing increased DNA damage markers
when CtIP is absent during reprogramming (Figure 3D).
We provide strong evidence that CtIP plays a role in avoid-
ing the genomic instability generated specifically during
cell reprogramming.
Normal CtIP Levels during Reprogramming Are
Required for Maintenance and Differentiation
of iPSCs
Due to the difficulty of expanding iPSC colonies fromMEFs
orHFFs reprogrammed in the absence of CtIP, wewondered(C) Reprogrammed HFF cells bearing the indicated shRNAs at day 10 w
caspase-3. A representative western blot is shown of three independe
(D) Percentage of positive cells for gH2AX. Other details as in (A).
(E) Reprogramming efficiency of human cells containing an IPTG-induc
analyzed in three independent experiments. Error bars indicate ±SEM
(F) Representative images of hiPSC morphology in cells harboring the
as indicated.
(G) Western blot analysis against the CtIP and OCT4 proteins in HF
presence (+) or absence () of IPTG. A representative western blot is
(H) Analysis of chromosomes per metaphase in iPSCs harboring IPTG-
absence () of IPTG. Tukey’s multiple comparison test was used with
See also Figure S2.
438 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017whether the genomic instability generated during reprog-
ramming in CtIP-downregulated cells affected self-renewal
and differentiation attributes. In fact, it is known that defi-
ciency in BRCA1, another protein involved in HR and DNA
end resection that interacts with CtIP, impairs mainte-
nance of iPSCs in culture (Gonzalez et al., 2013). To deepen
our understanding about the role of CtIP, we selected
several miPSC clones obtained in the presence of shCtIP
or a control shRNA. Taking advantage of the presence of
theGFP gene on the plasmid, we analyzed the permanence
of GFP cells in the colonies as a proxy for the presence of
the shRNA targeting CtIP. We determined that all control
shNT-harboring iPSC colonies maintained higher numbers
of GFP cells than shCtIP iPSCs, suggesting that the cells
that continued to grow and to maintain cell pluripotency
had a tendency to lose the cassette containing GFP and
the shRNA against CtIP (Figures 4A and 4B). Strikingly,
this effect was specific for iPSC cells that had been reprog-
rammed in the presence of shCtIP and was not observed
in primaryMEFs with shCtIP (Figure S4). Thus, collectively,
miPSC colonies reprogrammed with CtIP depletion had a
natural selection favoring cells with normal CtIP expres-
sion (Figure 4C). This could explain the high CtIP levels
in cells bearing shCtIP (Figure S2A). To study the kinetics
of loss of shCtIP expression, we sortedGFP-positivemiPSCs
generated from cells containing either shNT-GFP or shCtIP-
GFP and analyzed them for GFP disappearance during
growth (Figure 4D). We found that GFP cells were rapidly
purified from the cell population containing shCtIP-
GFP compared with control cells, with a reduction in
the number of GFP-positive cells of up to 50% after only
three passages. We next performed a self-renewal assay
using shCtIP- or shNT-miPSCs after enriching the pop-
ulations of shRNA-bearing cells by cell sorting, using
GFP as a marker. Again, reprogrammed cells depleted
for CtIP formed less-viable colonies than control cells
(Figures 4E and 4G). To differentiate whether this effect
of CtIP deficiency was due to defects gained during cell
reprogramming or those acquired during the plurip-
otent state of the reprogrammed cells, we transductedere immunoblotted to analyze for the proactive and active forms of
nt experiments.
ible shRNA against CtIP (shCtIP-IPTG) or the control shNT-IPTG was
. Statistical significance was performed using a t test.
inducible shCtIP-IPTG obtained in the presence or absence of IPTG,
F cells and hiPSC clones bearing the indicated shRNAs and in the
shown of three independent experiments.
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Figure 4. The Levels of CtIP During Re-
programming Affect iPSC Maintenance
(A) Percentage of GFP-positive cells in iPSC
colonies isolated after MEFs reprogramming
in the presence (white bars) or absence
(black bars) of CtIP.
(B) Representative bright field (BF) and GFP
images of miPSCs obtained by microscopy.
(C) Average percentage of GFP cells in
several clones of shNT and shCtIP iPSCs.
Error bars indicate ±SEM of different clones
(n = 6 and n = 10). Statistical analysis was
performed using a t test.
(D) Percentage of iPSCs harboring shCtIP-
GFP or shNT-GFP during subsequence pas-
sages of the cells. The average and SD of five
independent experiments is plotted. t test
analysis for each passage is shown. **p <
0.01, ***p < 0.005.
(E) The same amount of miPSCs re-
programmed either in the presence (white
bars) or absence (black bars) of CtIP were
seeded at low density and the number of
each colony was measured. The relative
number of colonies formed from three in-
dependent experiments is plotted. The t test
was performed to compare both conditions.
(F) Same as (E) but with cells reprogrammed
in the presence of CtIP, and then transduced
with an shRNA against CtIP (black bars) or
control shNT (white bars). Other details as
in (E). ns, not significant.
(G) miPSCs reprogrammed in the presence of
shCtIP or control shNT were immunoblotted
to analyze the indicated proteins. A repre-
sentative western blot is shown of three
independent experiments.
(H) Same as in (G) but with cells trans-
duced with an shRNA against CtIP after re-
programming.
See also Figures S4 and S5.already-reprogrammed iPSCs with either an shRNA against
CtIP or against a control sequence and analyzed them for
self-renewal by colony formation. Interestingly, in this
scenario, CtIP downregulation did not modify self-renewal
capacity compared with control cells (Figures 4F and 4H).
Along the same lines, the murine D3 embryonic stem cell
line (ES-D3) was not affected by CtIP depletion in self-
renewal experiments (Figures S5A–S5C).As self-renewal was compromised by inherited defects
aroused upon cell reprogramming in the absence of CtIP,
we wondered whether the differentiation process could
also be jeopardized in a similar way. Despite the difficulty
in expanding CtIP-deficient miPSCs, we were able to force
mouse embryonic body differentiation from several clones,
by removing the growth factor, leukemia inhibitory factor
(LIF) for 6 days. We observed that miPSCs reprogrammedStem Cell Reports j Vol. 8 j 432–445 j February 14, 2017 439
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Figure 5. CtIP Is Essential for Differentiation and Genomic Stability Maintenance in iPSCs
(A) Median size of embryonic bodies (EBs) generated at 6 days after spontaneous differentiation of miPSCs reprogrammed in the presence
of shCtIP or control shNT. At least 300 EBs of each condition were measured. The average and SD of five independent experiments is
plotted. Statistical significance was obtained by a t test.
(B) Representative images of EBs using BF and GFP filters.
(C) Western blot analysis of indicated proteins in EBs generated from miPSCs reprogrammed in the presence of shCtIP or control shNT.
A representative western blot is shown of three independent experiments.
(D) Same as in (A), but with cells reprogrammed in the presence of CtIP and then transduced with shCtIP or shNT as indicated. ns, not
significant.
(E) Same as in (C) but with cells transduced with shCtIP or shNT after reprogramming.
(F) Copy number variation (CNV) of genomic DNA between iPSCs obtained in the presence or absence of CtIP during cell reprogramming.
Two independent experiments (the first and second assays) are shown. CNVs were detected using SurePrint G3 Unrestricted CGH (4 3
180 K) arrays. See also Figure S5.under CtIP depletion also generated embryonic bodies
(EBs) smaller than their respective control cell reprog-
rammed in the presence of the control shNT, hence
showing a clear deficiency in differentiation (Figures 5A–440 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 20175C). We then tested if, as for self-renewal, this defect was
a consequence of problems inherent to reprogramming
in aCtIP-defective environment rather than a consequence
of the loss of an active role of CtIP in stem cell
differentiation. Indeed, CtIP downregulation in already-re-
programmed miPSCs (Figures 5D and 5E) or ES-D3 cells
(Figures S5D–S5F) did not affect their differentiation capac-
ity. Collectively, these data confirmed that genomic insta-
bility created during cell reprogramming under CtIP defi-
ciency is the main cause of impairment of self-renewal
and the differentiation process of miPSCs.
To strengthen our hypothesis, we analyzed copy number
variation (CNV) between early passes of shNT- or shCtIP-
iPSC clones (two of each). We found a large difference in
the number of CNV (>50 CNV) between miPSCs reprog-
rammed with CtIP depletion and their respective control
cells with shNT (Figure 5F).DISCUSSION
Genomic instability is one of the biggest concerns in the
potential clinical use of iPSCs (Rocha et al., 2013). The chal-
lenging field of regenerative medicine requires an in-depth
understanding of the causes and consequences of genetic
abnormalities that arise during the reprogramming process
(Studer et al., 2015; Tabar and Studer, 2014; Buganim et al.,
2013). Here, we study mouse and human reprogramming
to iPSCs, to elucidate the role of DNA end resection as a
relevant mechanism for avoiding genomic instability in
this process. We demonstrate that expression of the CtIP
protein, a key protein in DNA end resection (Sartori et al.,
2007), is upregulated during the formation of iPSCs and
is required for efficient reprogramming. A CtIP deficiency
during reprogramming not only drastically impairs the re-
programming process but also endangers the future of the
reprogrammed cells by critically limiting the maintenance
of their pluripotency state and their further differentiation
to EBs. All of these effects are likely caused by the genomic
aberrations acquired by cells during reprogramming. These
severe genomic consequences correlatewith thewell-estab-
lished roles of CtIP in DNA resection, HR, and DSB repair
pathway choice (Sartori et al., 2007; Huertas, 2010;
Gomez-Cabello et al., 2013; Lo´pez-Saavedra et al., 2016),
rather than reflecting a novel role of CtIP in the reprogram-
ming process. Intriguingly, and unexpectedly, the drastic
effects of these CtIP roles are highly specific to the cell-re-
programming process: CtIP depletion in already-estab-
lished iPSCs or ES cells does not reduce the ability of the
cells to self-renew or differentiate into EBs.We hypothesize
that this phenomenon is related to the load of endoge-
nously induced DNA damage in these different situations.
Cell reprogramming severely increases replication stress
and therefore DNA damage (Ruiz et al., 2015) (see also Fig-
ures 1G, 2F, 2D, 3D, and S2A), while endogenous DNA
damage in fibroblasts or iPSCs (under normal cell culture
conditions) is low. Thus, these differences in the amountof DNA damage could explain why CtIP is essential during
iPSC formation but not for maintenance of iPSCs or fibro-
blasts. Indeed, CtIP is essential for cell viability in cells
that have been exposed to mutagens that result in high
levels of DNA damage (Sartori et al., 2007; Huertas and
Jackson, 2009) or chromosomal aberrations (Huertas and
Jackson, 2009). Strikingly, and in agreement with this
idea, our data suggest that cell reprogramming in wild-
type human and mouse fibroblasts causes an increase in
DNA resection that is comparable with high doses of
ionizing radiation (Figure S1).
DDR and DNA repair genes have been shown to control
genetic stability during cell reprogramming (Lu et al., 2016;
Rocha et al., 2013; Hong et al., 2009; Kawamura et al., 2009;
Li et al., 2009). Along those lines, we have now demon-
strated that DNA end resection, a key process in DSB
repair by HR, is hyper-activated in cells undergoing reprog-
ramming compared with the parental somatic cells or
already-differentiated cells. During reprogramming, cells
not only have an increase in the amount of breaks that
are resected, but also a gain in processivity, measured as
the length of resected DNA. The most likely explanation
for upregulation of DNA end resection is the occurrence
of DNA damage during reprogramming. This idea is sup-
ported by an increase in the gH2AX marker levels after
expression of reprogramming factors, as observed by us
and others (Ruiz et al., 2015; Gonzalez et al., 2013; Tilgner
et al., 2013). Replication stress, due to the presence of a
stalled replication fork, is a major generator of DNA dam-
age, and this is commonly resolvedmainly by HR ormicro-
homology-mediated end joining (Petermann andHelleday,
2010; Aguilera and Gomez-Gonzalez, 2008). Hence, the
occurrence of DNA damage by replication stress during
iPSC development could explain both the upregulation
and essential role of DNA end resection in reprogramming.
Here we show that CtIP, a bona fide regulator of DNA end
resection (Huertas and Jackson, 2009; Huertas et al., 2008;
Sartori et al., 2007), is upregulated during cell reprogram-
ming, and that it is essential for this process. Similarly,
CHK1 has been suggested to be pertinent to generating
iPSCs (Ruiz et al., 2015). CtIP is known to be a key player
in maintaining genomic stability, and we reasoned that
CtIP could be appropriately activated to repair DSBs gener-
ated by the presence of reprogramming factors. Selective
CtIP depletion during mouse and human cell reprog-
ramming interferes with iPSC generation and triggers
apoptosis. In agreement with these data, BRCA1, which ac-
celerates DNA resection through its interaction with CtIP
(Cruz-Garcia et al., 2014), is also required for successful
reprogramming (Gonzalez et al., 2013). In addition, other
proteins linked to HR repair, such as BRCA2 and RAD51,
are critical for cell reprogramming, at least in mice (Gonza-
lez et al., 2013).Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017 441
We also observed that CtIP depletion during cell reprog-
ramming in mouse and human cells hampers the growth
and maintenance of their derived iPSCs. As a matter of
fact, the human C1 clone obtained from cells bearing an
inducible shRNA in the presence of IPTG showed the
same long-term problems in viability regardless of the
restoration of CtIP expression (data not shown, see Fig-
ure 3G for CtIP expression recovery). Likewise, Brca1-defi-
cient MEFs have problems for cell reprogramming, and
the derived iPSCs are unable to establish colonies (Gonza-
lez et al., 2013). This clearly differentiates proteins involved
in early steps of HR, such as CtIP and BRCA1 in resection,
from those affecting later steps, such as BRCA2 and
RAD51, which are in fact dispensable for iPSC colony
expansion (Gonzalez et al., 2013). We reasoned that iPSCs
are defective for DNA end resection, which is critical for
choosing between HR and NHEJ (Gomez-Cabello et al.,
2013). As mentioned before, we suggest that both pluripo-
tent and differentiated cells can likely repair their DNA by
bothNHEJ andHR, such that eliminating one of them only
has a mild effect on cell viability unless an exogenous
source of damage is present. However, during cell reprog-
ramming, recombination is the only mechanism able to
deal with the endogenous damage. We postulate that this
is due to the nature of the DNA lesion, as replication stress
will readily cause the appearance of one-ended DNA DSBs
and will require recombination to restore replication. In
the absence of CtIP, those breaks would be erroneously re-
paired, inducing the observed chromosomal abnormalities
and CNV differences (Figures 3H and 5F). Indeed, this
seems to be a recurrent mechanism that causes cells under-
going reprogramming to acquire a high degree of chromo-
somal instability. Even by analyzing cells from a single
clone that differentiated in the absence of CtIP (the C1
clone), we can observe that each metaphase has a different
number of chromosomes (Figure 3H). Thus, in the absence
of CtIP, DSBs created by replication stress would be re-
paired through more mutagenic repair pathways, thereby
increasing mutagenesis and chromosomal rearrangements
(Bunting et al., 2010). This is consistent with an increase in
DNA damage and genetic instability and would ultimately
lead to apoptosis during reprogramming.
We could not expand the only clone we were able to
obtain from CtIP-depleted hiPSCs (C1), but did establish
a few clones from CtIP-depleted miPSCs, albeit with low
efficiency. These clones showed high levels of alterations
in chromosome number and CNV with respect to iPSCs
generated under normal CtIP levels. These data are consis-
tent with early embryonic lethality (E4.0) observed for
CtIP knockout mice, which shows a slightly elevated
apoptosis (Chen et al., 2005). Although this lethality
has been previously associated with the retinoblastoma
protein, our data support the idea that the resection func-442 Stem Cell Reports j Vol. 8 j 432–445 j February 14, 2017tion of CtIP is required for embryonic viability (Polato
et al., 2014). Curiously, we found that established plurip-
otent cells, namely miPSCs and ES-D3 cells, did not
require CtIP protein (at least not in the absence of an
exogenous source of DNA damage). Cell reprogramming
seems to be one such source of internal stress, so it is
possible that other situations arise during normal embryo-
genesis in which CtIP, and specifically its resection activ-
ity, are essential.
Our data and those from previous reports suggest that
cells from patients with deficient DDR and DNA repair
pathways could not be efficiently reprogrammed and
used in regenerative medicine. However, more in-depth
investigations are needed to clarify which genes are specif-
ically required to avoid genomic instability during the
reprogramming process, to grant this powerful tool a
future as a clinical standard procedure. Indeed, we suggest
that, when studying self-renewal and differentiation of
iPSCs, it is of capital importance to discriminate between
the actual roles of repair proteins on those processes
and the inherent, long-term consequences of genomic
instability caused by reprogramming in a repair-defective
environment.EXPERIMENTAL PROCEDURES
Cell Cultures
HEK293T, SNL, and C57BL/6 primary MEFs carrying a doxycy-
cline-inducible tetracistronic cassette encoding the fourmurine re-
programming factors Oct4, Sox2, Klf4, and c-Myc (provided by
M. Serrano) (Abad et al., 2013) were grown in DMEM (Sigma-
Aldrich) supplemented with 10% fetal bovine serum (FBS)
(Sigma-Aldrich), 100 units/mL penicillin and 100 g/mL strepto-
mycin (Sigma-Aldrich). HFF cells were growth in DMEM (Gibco)
supplemented with 20% FBS (ATCC, LGC Promochem) and
100 units/mL penicillin (Sigma-Aldrich). miPSCs were cultured
on gelatin-coated plates with DMEM/F12 + GlutaMAX (Gibco)
supplemented with 20% knockout serum replacement (Gibco),
1,000 U/mL LIF (Millipore), 1% non-essential amino acids,
0.1 mM b-mercaptoethanol, and 100 units/mL penicillin (Sigma-
Aldrich). hiPSCs were cultured on SNL feeders with DMEM/F12 +
GlutaMAX (Gibco) supplemented with 20% knockout serum
replacement (Gibco), 10 ng/mL basic fibroblast growth factor
(Miltenyi Biotec), 1% non-essential amino acids, 0.1 mM b-mer-
captoethanol, and 100 units/mL penicillin (Sigma-Aldrich).Retroviral and Lentiviral Production
Retroviral and lentiviral particles were produced in HEK293T cells
as described previously (Gomez-Cabello et al., 2013) using the plas-
mids listed in Table S1. Lentiviruses harboring shRNA vectors
(Sigma) targeting human CtIP (CAG AAG GAT GAA GGA CAG
TTT), mouse CtIP (GCA AGG TTT ACA AGT CAA AGT), and a
non-target sequence (GCG CGA TAG CGC TAA TAA TTT) were
used.
Mouse and Human iPSC Reprogramming
For miPSCs, MEFs were seeded at 1.5 3 105 cells per well of a
12-well plate. MEFs were cultured in miPSC medium supple-
mented with 1 mg/mL doxycycline to induce the expression of
OSKM and promote reprogramming. Medium was changed every
24 hr for 21 days or until iPSCs colonies appeared. iPSCs were
then expanded in 6-well gelatin-coated plates and in iPSCmedium
without doxycycline. For hiPSCs, HFFs with low number of passes
were incubated with retroviral supernatants containing OCT4,
c-MYC, SOX2, and KLF4 three times for 48 hr each time. Cells
were then plated on irradiated (45 Gy) SNL feeders, the medium
was changed 1 day later to iPSCmedium, and cells were incubated
for a further 21–30 days. For IPTG induction reprogramming, HFFs
were transduced with an IPTG-inducible shCtIP lentivirus or the
respective shNT lentivirus as a control. After 48 hr, iPSC regular
medium with 1 mM IPTG (Sigma) was added to start the reprog-
ramming process and maintained during the whole process. Re-
programming efficiency was calculated as the number of colonies
normalized to the number of cells seeded.
Single-Molecule Analysis of Resection Tracks
iPSCs and differentiated cells (MEFs and HFFs) were seeded in
6-well plates at the required density to reach 80% confluence at
the time of harvest. Cells were grown in the presence of 10 mM
BrdU (GE Healthcare) for 24 hr and then harvested. Single-mole-
cule analysis of resection tracks (SMART) was performed as
described previously (Cruz-Garcia et al., 2014).
Immunoblotting
Protein extracts were prepared in Laemmli buffer (4% SDS/20%
glycerol, 120 mM Tris-HCl [pH 6.8]). Proteins were resolved by
SDS-PAGE, transferred to polyvinylidene fluoride (Millipore)mem-
brane and visualized by immunoblotting. Western blot analysis
used the antibodies listed in Table S2. Results were visualized and
quantified using an Odyssey Infrared Imaging System (LI-COR
Biosciences).
Flow-Cytometric Analysis of DNA End Resection
MEF cells, HFF cells, hiPSCs, and miPSCs were prepared for FACS
analysis as follows: cells were grown in the presence of 10 mM
BrdU (GE Healthcare) for 16–18 hr and then detached using Accu-
tase (eBioscence). Cells grown in absence of BrdU were used as
FACS-negative control. Cells were fixed with 4% paraformalde-
hyde for 10 min at 4C, permeabilized with 0.1% Triton X-100 in
PBS, washed in PBS, and then blocked with 5% FBS in PBS. After
blocking, cells were incubated with an anti-BrdU mouse mono-
clonal antibodies (Table S2) for 1–2 hr at room temperature, and
then with the appropriate secondary antibody (Table S2) for
30 min at room temperature. Additional control cells without pri-
mary antibody were used to set up FACS conditions. Cells were
then washed and resuspended in PBS. Samples were analyzed
with a BD FACSCalibur flow cytometer (BD Biosciences, Ref:
342975). At least 10,000 events were recorded for each sample.
Flow-Cytometric Analysis Cell Cycle
Mouse and hiPSCs were grown in 6-well plates. After 2 days, Accu-
tase was added to remove the cells, which were then fixed with70% ethanol at 4C for at least 1 day. Cells were then washed
and resuspended in PBS. Samples were incubated with 1 mg/mL
propidium iodide and 10 mg/mL RNase (Sigma) for 20 min prior
to FACS analysis. Samples were analyzed with a BD FACSCalibur
flow cytometer (BD Biosciences). At least 10,000 events were re-
corded for each sample.
Karyotyping
hiPSCs were grown for 48 hr on gelatinized 6-well plates. At 3 hr
prior to cell collection, the medium was changed and supple-
mentedwith 0.1 mg/mL demecolcine (Sigma, D7385) for 2 hr. Cells
were washed, detached with Accutase, and centrifuged at 200 3 g
for 5 min at 4C. iPSCs were then resuspended in hypotonic KCl
solution (0.56%) and incubated at 37C for 10 min. Cells under-
went two rounds of fixation in methanol:glacial acetic acid (3:1)
and centrifugation, after which they were resuspended in fixation
solution and stained with DAPI. DAPI-stained chromosomes from
at least 75 cells were counted for each condition.
EBs
miPSCs growing in gelatinized 6-well plates were detached
with Accutase, counted, and replated onto ultra-low attachment
6-well plate with iPSC regular medium without LIF for 3–4
days. EBs were analyzed for size and number through microscopic
imagesusingAdobePhotoshopCS6 (Adobe Systems Incorporated).
Array Comparative Genomic Hybridization
For mouse array comparative genomic hybridization, CNVwas de-
tected from genomic DNA isolated from iPSC clones and hybrid-
ized to SurePrint G3 Human High-Resolution 13 1 MMicroarrays
(CNV) (Agilent Technologies) following manufacturer’s instruc-
tions. CNV was identified using Agilent CytoGenomics v2.0 anal-
ysis software, following ADM-2 algorithm suggested by Agilent
Technologies.
All iPSC clones were obtained at early passes after reprogram-
ming and colony selection.
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